Perspectives on oral pulmonary hypertension therapies recently approved by the U.S. food and drug administration

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)959
Number of pages1
JournalAnnals of the American Thoracic Society
Volume12
Issue number6
DOIs
StatePublished - Jun 1 2015

Fingerprint

Pyrazoles
Pyrimidines
Sulfonamides
Epoprostenol
United States Food and Drug Administration
Pulmonary Hypertension
Antihypertensive Agents
Therapeutics
Endothelin Receptor Antagonists

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

@article{5d3724e41f974818ac90f70e502c420b,
title = "Perspectives on oral pulmonary hypertension therapies recently approved by the U.S. food and drug administration",
author = "Burger, {Charles Dwayne}",
year = "2015",
month = "6",
day = "1",
doi = "10.1513/AnnalsATS.201503-114LE",
language = "English (US)",
volume = "12",
pages = "959",
journal = "Annals of the American Thoracic Society",
issn = "2325-6621",
publisher = "American Thoracic Society",
number = "6",

}

TY - JOUR

T1 - Perspectives on oral pulmonary hypertension therapies recently approved by the U.S. food and drug administration

AU - Burger, Charles Dwayne

PY - 2015/6/1

Y1 - 2015/6/1

UR - http://www.scopus.com/inward/record.url?scp=84942233484&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942233484&partnerID=8YFLogxK

U2 - 10.1513/AnnalsATS.201503-114LE

DO - 10.1513/AnnalsATS.201503-114LE

M3 - Article

C2 - 26075561

AN - SCOPUS:84942233484

VL - 12

SP - 959

JO - Annals of the American Thoracic Society

JF - Annals of the American Thoracic Society

SN - 2325-6621

IS - 6

ER -